Sorted by: Date | Title

Leonard Zon, MD

Alex’s Lemonade Stand Foundation awards $4.95 million to Dana-Farber/Boston Children’s researchers as part of its Crazy 8 Initiative to advance pediatric cancer research

March 16, 2021
The grant was given to Leonard Zon, MD, of Boston Children’s Hospital who will collaborate extensively with other scientists at Boston Children’s Hospital and Dana-Farber Cancer Institute, including Scott A. Armstrong, MD, PhD; Vijay G. Sankaran, MD, PhD; Fernando Camargo, PhD; and Serine Avagyan, MD, PhD.
Lisa B. Kenney, MD, MPH

Childhood cancer survivors, providers satisfied with video visits for long-term follow-up

March 04, 2021
A report by Dana-Farber/Boston Children's researchers on the study of video conferencing was published in the journal Pediatric Blood and Cancer.
Boston Magazine Top Docs (2021)

Dana-Farber/Boston Children's Faculty Named 2021 Top Doctors

January 05, 2021
Boston magazine has named a number of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center faculty members to its annual "Top Doctors" guide.
Amazon donation

Amazon surprises Dana-Farber/Boston Children’s with a $500,000 donation during Childhood Cancer Awareness Month

September 28, 2020
The gift will support pediatric research, holiday gifts, and virtual events for pediatric patients and their families as part of the company’s global Amazon Goes Gold campaign during Childhood Cancer Awareness Month.
US News 2020 rankings badge

Dana-Farber/Boston Children's named a top pediatric cancer program

June 16, 2020
U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the top pediatric cancer program in New England and #2 in the nation in its 2020-21 Best Children's Hospitals report.
Lisa R. Diller, MD

Population-based registry data identifies novel cancer patterns in families of childhood cancer patients

May 20, 2020
A collaboration between the Finnish Cancer Registry and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center explored the utility of population-based registry data to screen childhood cancer patients for history of familial cancer. The study opened a new method for identifying high risk families that may reveal possible novel cancer predisposition genes.
Keith Ligon, MD, PhD

Massive study reveals how 'hypermutated' malignant brain tumors with many mutations escape chemotherapy and immunotherapy

April 15, 2020
The report’s authors include investigators from Dana-Farber, Brigham and Women’s, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, the Broad Institute of MIT and Harvard, and Pitié-Salpêtrière hospitals in Paris, France, among others.
Hyundai Hope on Wheels logo

Dana-Farber/Boston Children’s receives $200,000 grant from Hyundai Hope On Wheels to support COVID-19 testing

April 08, 2020
Dana-Farber/Boston Children’s physicians have implemented crucial testing protocols during this unusual time, with a focus that children with cancer need life-saving treatments even in the setting of a viral pandemic.
Katherine A. Janeway, MD

The Osteosarcoma Institute to fund clinical trial in recurrent osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

February 27, 2020
The clinical trial will investigate the effectiveness of a combination of two oral drugs targeting the DNA damage response pathway.
Daphne Haas-Kogan, MD

Hass-Kogan receives funding for new DIPG-specific research project from Defeat DIPG and ChadTough

January 29, 2020
Daphne Haas-Kogan, of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, will receive a research grant totaling $600,000 over three years for “Dependence of DIPGs on DNA polymerase q for DNA repair defines a new therapeutic target.”
Showing 1-10 of 138 items